TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Orifarm Generics A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
286,859
|
279,014
|
236,320 |
| Earnings before taxes |
10,769
|
9,351
|
25,651 |
| Total assets |
185,486
|
180,894
|
157,622 |
| Current assets |
178,748
|
174,530
|
151,459 |
| Current liabilities |
117,660
|
121,435
|
85,347 |
| Equity capital |
66,370
|
58,056
|
70,903 |
| - share capital |
134
|
134
|
134 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
35.8%
|
32.1%
|
45.0% |
| Turnover per employee |
1,912
|
1,860
|
1,575 |
| Profit as a percentage of turnover |
3.8%
|
3.4%
|
10.9% |
| Return on assets (ROA) | |||
| Current ratio |
151.9%
|
143.7%
|
177.5% |
| Return on equity (ROE) |
16.2%
|
16.1%
|
36.2% |
| Change turnover |
8,466
|
42,694
|
143,744 |
| Change turnover % |
3%
|
18%
|
155% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.